b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31717968</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>31</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>31</Day>\n        </DateRevised>\n        <Article PubModel="Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1422-0067</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>20</Volume>\n                    <Issue>22</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Nov</Month>\n                        <Day>11</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>International journal of molecular sciences</Title>\n                <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>The Bile Acid-Phospholipid Conjugate Ursodeoxycholyl-Lysophosphatidylethanolamide (UDCA-LPE) Disintegrates the Lipid Backbone of Raft Plasma Membrane Domains by the Removal of the Membrane Phospholipase A2.</ArticleTitle>\n            <ELocationID EIdType="pii" ValidYN="Y">E5631</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms20225631</ELocationID>\n            <Abstract>\n                <AbstractText>The bile acid-phospholipid conjugate ursodeoxycholyl-lysophosphatidylethanolamide (UDCA-LPE) was shown to have anti-inflammatory, antisteatotic, and antifibrotic properties, rendering it as a drug targeting non-alcoholic steatohepatitis (NASH). On a molecular level, it disrupted the heterotetrameric fatty acid uptake complex localized in detergent-resistant membrane domains of the plasma membrane (DRM-PM). However, its mode of action was unclear. Methodologically, UDCA-LPE was incubated with the liver tumor cell line HepG2 as well as their isolated DRM-PM and all other cellular membranes (non-DRM). The membrane cholesterol and phospholipids were quantified as well as the DRM-PM protein composition by Western blotting. The results show a loss of DRM-PM by UDCA-LPE (50 \xc2\xb5M) with a 63.13 \xc2\xb1 7.14% reduction of phospholipids and an 81.94 \xc2\xb1 8.30% reduction of cholesterol in relation to mg total protein. The ratio of phospholipids to cholesterol changed from 2:1 to 4:1, resembling those of non-DRM fractions. Among the members of the fatty acid uptake complex, the calcium-independent membrane phospholipase A2 (iPLA<sub>2</sub>\xce\xb2) abandoned DRM-PM most rapidly. As a consequence, the other members of this transport system disappeared as well as the DRM-PM anchored fibrosis regulating proteins integrin \xce\xb2-1 and lysophospholipid receptor 1 (LPAR-1). It is concluded that UDCA-LPE executes its action by iPLA<sub>2</sub>\xce\xb2 removal from DRM-PM and consequent dissolution of the raft lipid platform.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Stremmel</LastName>\n                    <ForeName>Wolfgang</ForeName>\n                    <Initials>W</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Staffer</LastName>\n                    <ForeName>Simone</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Internal Medicine IV, University Hospital of Heidelberg, 69120 Heidelberg, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Fricker</LastName>\n                    <ForeName>Gert</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Weiskirchen</LastName>\n                    <ForeName>Ralf</ForeName>\n                    <Initials>R</Initials>\n                    <Identifier Source="ORCID">0000-0003-3888-0931</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry, RWTH University Hospital Aachen, 52074 Aachen, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>11</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Switzerland</Country>\n            <MedlineTA>Int J Mol Sci</MedlineTA>\n            <NlmUniqueID>101092791</NlmUniqueID>\n            <ISSNLinking>1422-0067</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D019012">Integrin beta1</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C000609549">LPAR1 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008246">Lysophospholipids</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D049368">Receptors, Lysophosphatidic Acid</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C000598975">ursodeoxycholyl lysophosphatidylethanolamide</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>724L30Y2QR</RegistryNumber>\n                <NameOfSubstance UI="D014580">Ursodeoxycholic Acid</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>97C5T2UQ7J</RegistryNumber>\n                <NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.1.1.4</RegistryNumber>\n                <NameOfSubstance UI="D054467">Phospholipases A2</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D056945" MajorTopicYN="N">Hep G2 Cells</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019012" MajorTopicYN="N">Integrin beta1</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008246" MajorTopicYN="N">Lysophospholipids</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D021962" MajorTopicYN="N">Membrane Microdomains</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D054467" MajorTopicYN="N">Phospholipases A2</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D049368" MajorTopicYN="N">Receptors, Lysophosphatidic Acid</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014580" MajorTopicYN="N">Ursodeoxycholic Acid</DescriptorName>\n                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">NASH</Keyword>\n            <Keyword MajorTopicYN="N">UDCA-PLE</Keyword>\n            <Keyword MajorTopicYN="N">fatty acids</Keyword>\n            <Keyword MajorTopicYN="N">fibrosis</Keyword>\n            <Keyword MajorTopicYN="N">inflammation</Keyword>\n            <Keyword MajorTopicYN="N">liver</Keyword>\n            <Keyword MajorTopicYN="N">steatosis</Keyword>\n            <Keyword MajorTopicYN="N">therapy</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>09</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>28</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>06</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>4</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31717968</ArticleId>\n            <ArticleId IdType="pii">ijms20225631</ArticleId>\n            <ArticleId IdType="doi">10.3390/ijms20225631</ArticleId>\n            <ArticleId IdType="pmc">PMC6888454</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S79-84</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17567474</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Semin Liver Dis. 2001 Aug;21(3):351-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11586465</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Sep;1862(9):917-928</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28602806</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>FASEB J. 2014 Jul;28(7):3159-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24719358</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Physiol Biochem. 2010;26(3):273-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20798511</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Hepatol. 2011 Apr;54(4):674-84</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21146893</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Chem Rev. 2011 Oct 12;111(10):6130-85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21910409</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2018 May 24;13(5):e0197836</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29795632</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Pharmacol. 2014 Nov;171(22):5113-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25041068</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Sci. 2011 Dec 1;124(Pt 23):3933-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22194304</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochim Biophys Acta. 2007 Jun;1768(6):1311-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17493580</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Cell Biol. 2006 Oct;18(5):516-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16919435</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Sci. 2015 Jun 1;128(11):2179-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25908865</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Prog Lipid Res. 2015 Jul;59:38-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25969421</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hepatology. 2009 Jul;50(1):143-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19496180</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>EMBO J. 2006 Aug 9;25(15):3446-57</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16900097</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2018 Feb 22;9(1):765</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29472584</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hepatology. 2012 May;55(5):1369-78</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22183915</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Invest. 2002 Sep;110(5):597-603</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12208858</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Sci. 2018 Oct 20;19(10):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30347788</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gastroenterology. 2010 Jan;138(1):347-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19782079</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'